Brighthouse Financial, Inc.
BHFAM- Exchange
- Nasdaq
- Industry
- Life Insurance
- SEC CIK
- 0001685040
No open-market purchases or sales by Brighthouse Financial, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:56 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 23, 2026 | Feb 11, 2025 | Feb 12, 2024 | Feb 9, 2023 | Feb 10, 2022 |
| Revenue | $6.77B | $4.72B | $4.12B | $8.47B | $7.14B |
| Operating expenses | $1.96B | $1.95B | $1.98B | $2.08B | $2.45B |
| Interest expense | $152.0M | $152.0M | $153.0M | $153.0M | $163.0M |
| Income tax | $36.0M | $29.0M | -$367.0M | -$182.0M | -$105.0M |
| Net income | $433.0M | $388.0M | -$1.11B | $5.00M | -$108.0M |
| EPS, basic | $5.75 | $4.67 | $-18.39 | $-1.36 | $-2.36 |
| EPS, diluted | $5.71 | $4.64 | $-18.39 | $-1.36 | $-2.36 |
| Weighted shares, basic | 57.5M | 61.2M | 66.0M | 73.0M | 83.8M |
| Weighted shares, diluted | 57.9M | 61.6M | 66.0M | 73.0M | 83.8M |
| Margins and growth | |||||
| Net margin | 6.4% | 8.2% | -27.0% | 0.1% | -1.5% |
| Revenue growth, year over year | +43.2% | +14.7% | −51.4% | +18.6% | −16.0% |
| Net income growth, year over year | +11.6% | – | −22,340.0% | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 23, 2026 | Feb 11, 2025 | Feb 12, 2024 | Feb 9, 2023 | Feb 10, 2022 |
| Cash and equivalents | – | – | – | – | $4.47B |
| Short-term investments | – | $1.87B | $1.17B | $1.08B | $1.84B |
| Total assets | $241.8B | $238.5B | $236.3B | $225.6B | $259.8B |
| Long-term debt | $3.15B | $3.15B | $3.16B | $3.16B | $3.16B |
| Total liabilities | $235.0B | $233.5B | $231.3B | $219.5B | $243.6B |
| Shareholders' equity | $6.83B | $5.02B | $5.01B | $6.04B | $16.2B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 23, 2026 | Feb 11, 2025 | Feb 12, 2024 | Feb 9, 2023 | Feb 10, 2022 |
| Operating cash flow | $259.0M | -$290.0M | -$137.0M | -$1.15B | $746.0M |
| Stock-based compensation | $42.0M | $23.0M | $29.0M | $22.0M | $23.0M |
| Share buybacks | $102.0M | $250.0M | $250.0M | $488.0M | $499.0M |
| Investing cash flow | $751.0M | -$2.19B | -$3.20B | -$8.28B | -$12.2B |
| Financing cash flow | -$668.0M | $3.68B | $3.07B | $9.07B | $11.9B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.6% | 0.5% | 0.7% | 0.3% | 0.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 57.5M | +0.6% | SEC |
| Jul 31, 2026 | 57.5M | +0.6% | SEC |
| May 1, 2026 | 57.4M | +0.1% | SEC |
| Feb 20, 2026 | 57.2M | −1.5% | SEC |
| Oct 31, 2025 | 57.2M | −3.7% | SEC |
| Aug 4, 2025 | 57.2M | −5.9% | SEC |
| May 6, 2025 | 57.4M | −7.6% | SEC |
| Feb 21, 2025 | 58.1M | −7.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.